TGTX R&D Expense Growth
Tg Therapeutics Inc · R&D Expense Growth
TGTX R&D Expense Growth
Latest reported69.92%period ending
TGTX FY R&D Growth (YoY) (0.00% → 69.92%)
Latest values, visible window
High-resolution chart · PNG
TGTX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 69.9155% | |
| 23.7545% | |
| -39.2176% | |
| -43.682% | |
| 34.1678% | |
| 7.5989% | |
| 0.2516% | |
| 58.7358% | |
| 45.7157% | |
| 53.0408% | |
| 38.562% | |
| 148.4302% | |
| -38.6494% | |
| 6,185.7472% | |
| -33.988% | |
| 1,127.9399% | |
| -97.7604% | |
| -78.8794% | |
| 38.278% | |
| -63.8293% | |
| 310.9297% | |
| 140.8869% | |
| 219.4139% | |
| -39.1291% | |
| -21.5535% | |
| 2.7586% | |
| -63.3333% | |
| 15.3846% | |
| 136.3636% | |
| 0% |